SGLT2 inhibitor patient volume exhibited consistent and substantial growth between 2018 and 2023, with a 23.3% increase from 2018 to 2019 and a 231.7% increase by 2023 relative to the 2018 baseline
The scope of this expert opinion is to aid in clinical decision-making for the appropriate use of the SGLT-2i and DPP-4i FDCs in T2DM management
One common reason is metabolic adaptation, where your body becomes more efficient at using fewer calories, thereby slowing down weight loss
Once your body adjusts to your new weight and nutrient intake stabilises, hair growth often returns to normal within 36 months
Legal and common, but it changes how insurers treat coverage
Effects and Management Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly prescribed for type 2 diabetes and weight management, but many patients wonder: does GLP-1 slow down digestion